CHCLX | FSMAX | CHCLX / FSMAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 87 years | 13 years | - |
Gain YTD | -2.211 | 0.341 | -648% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.62B | 41.9B | 6% |
Annual Yield % from dividends | 0.00 | 1.10 | - |
Returns for 1 year | 7.68 | 15.39 | 50% |
Returns for 3 years | 10.15 | 24.35 | 42% |
Returns for 5 years | -0.09 | 41.45 | -0% |
Returns for 10 years | 22.60 | 72.15 | 31% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHLAX | 35.05 | -0.19 | -0.54% |
PGIM Jennison Health Sciences A | |||
TRIFX | 4.89 | -0.05 | -1.01% |
Catalyst/SMH Total Return Income A | |||
AIMOX | 15.15 | -0.22 | -1.43% |
AQR International Momentum Style I | |||
TIGRX | 15.21 | -0.32 | -2.06% |
Nuveen Core Equity R6 | |||
BPSCX | 24.43 | -0.53 | -2.12% |
Boston Partners Small Cap Value II Inv |